EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Langerhans Cell Modulation in Atopic Dermatitis Is TLR2 / SOCS1 ‐Dependent and JAK Inhibitor‐Sensitive

Yuxuan Deng, Nicole Leib, Sylvia Schnautz, Said Benfadal, Johannes Oldenburg, Thomas Bieber, Nadine Herrmann iD

Allergy · 2025

DOI: 10.1111/all.16641 ↗

At a glance

Journal article in Allergy, 2025. Written by Yuxuan Deng and 6 co-authors. Institution: Center for Skin Diseases, University Hospital Bonn, Bonn, Germany. Major MEDLINE topics: Toll-Like Receptor 2, Dermatitis, Atopic, Langerhans Cells, Suppressor of Cytokine Signaling 1 Protein. 78 references. The full text is freely available (open access, CC BY 4.0). Funded by: Christine Kühne - Center for Allergy Research and Education, Deutsche Forschungsgemeinschaft, Christine Kühne – Center for Allergy Research and Education.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Langerhans cells (LC) are epidermal dendritic cells building the skin's outermost immunological barrier and bridging innate and adaptive immune responses. Their sensing property of the microbiome via Toll‐like receptors (TLR) is impaired in atopic dermatitis (AD). We hypothesize a desensitization of LC because of persistent Staphylococcus aureus exposure in AD and underlying mechanisms being TLR2‐related.

Methods

Human LC generated from hematopoetic stem cells were desensitized via repetitive exposure to TLR2‐ligands (priming) and compared to unprimed cells for their TLR‐responsiveness. JAK inhibitors impact was evaluated. Maturation marker, migration marker and behavior, cytokine release, and downstream molecule regulation were addressed by flow cytometry, qPCR, and transwell and multiplex assays.

Results

Primed LC mimicked the LC behavior in AD skin, exhibiting desensitization toward TLR2‐mediated activation monitored by impaired CD83/CD80/CD86 and MHCII expression as well as impaired regulation of chemokines CCR6 and CCR7, migration competence, and Th17‐driving cytokines. IL‐18 and IL‐1β were elevated under these conditions. Negative regulators of the TLR2 pathway, specifically SOCS1 and IRAKM, were significantly upregulated, whereas activating molecules were hardly affected. JAK inhibitors reduced SOCS1 expression in primed cells and restored activation markers CD83/80/86 and MHCII upon TLR2 engagement, but had no effect on IRAKM expression.

Conclusion

Primed LC mimic the impaired LC‐responsiveness toward TLR2 in AD skin. Our findings unravel a new direct contribution of LC to AD‐associated IL‐1β and IL‐18 under these conditions and shed light on the mechanistical role of SOCS1 and the mode of action of JAK inhibitors.

Subjects

MeSH terms (MEDLINE)

Toll-Like Receptor 2Dermatitis, AtopicLangerhans CellsSuppressor of Cytokine Signaling 1 ProteinJanus Kinase InhibitorsHumansCytokinesSignal Transduction

Author keywords

JAK/STATLangerhans cellsTLR2atopic dermatitismicrobiome

Substances

Toll-Like Receptor 2Suppressor of Cytokine Signaling 1 ProteinJanus Kinase InhibitorsSOCS1 protein, humanTLR2 protein, humanCytokines

Authors and institutions

  • Center for Skin Diseases, University Hospital Bonn, Bonn, Germany.
  • Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
  • Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
  • Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
  • Bieber Dermatology Consulting, Bonn, Germany.

ORCID profiles: Nadine Herrmann

Funding

  • Christine Kühne - Center for Allergy Research and Education
  • Deutsche Forschungsgemeinschaft
  • Christine Kühne – Center for Allergy Research and Education

Cite

APA

Deng, Y., Leib, N., Schnautz, S., Benfadal, S., Oldenburg, J., Bieber, T., & Herrmann, N. (2025). Langerhans Cell Modulation in Atopic Dermatitis Is TLR2 / SOCS1 ‐Dependent and JAK Inhibitor‐Sensitive. Allergy. https://doi.org/10.1111/all.16641

Vancouver

Deng Y, Leib N, Schnautz S, Benfadal S, Oldenburg J, Bieber T, et al. Langerhans Cell Modulation in Atopic Dermatitis Is TLR2 / SOCS1 ‐Dependent and JAK Inhibitor‐Sensitive. Allergy. 2025. doi:10.1111/all.16641

BibTeX
@article{Deng2025,
  author = {Deng, Yuxuan and Leib, Nicole and Schnautz, Sylvia and Benfadal, Said and Oldenburg, Johannes and Bieber, Thomas and Herrmann, Nadine},
  title = {Langerhans Cell Modulation in Atopic Dermatitis Is TLR2 / SOCS1 ‐Dependent and JAK Inhibitor‐Sensitive},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16641}
}
Start for free →